Proteus, S.A. Granted U.S. Patent For Screening Active Compounds Using In Vitro Protein Expression
10/19/2005 5:12:18 PM
Proteus today announced the issuance of a new U.S. Patent addressing the functional screening of candidate active compounds using in vitro protein expression. The patent granted represents the latest addition to Proteus Phenomics(TM) proprietary technology. This embodiment is suited for a broad variety of functional proteomic applications such as activity screening, kinetics or inhibition studies.
comments powered by